We use cookies to personalize your experience, track visits, and analyze traffic. Learn more.
Resources to navigate psychedelic care with greater confidence.
Explore peer support and a growing library of tools, media, and research to better understand and navigate the impacts of psychedelic treatments.
We bridge scientific research and clinical practice with the perspectives of people who have lived with diagnoses and undergone psychedelic treatments.
Whether you’re a clinician, researcher, advocate, patient, trial participant, or caregiver, this space aims to bring together relevant research, conversations, and lived experience insights.
Along with our peer support circles, we’re building a library of podcasts, books, academic research, media, offering nuanced, real-world perspectives on psychedelic research and care.
Find community in peer-led support groups to process your experiences, integrate insights, and navigate both the breakthroughs and challenges of psychedelic treatments.
These sessions provide a confidential, peer-led and empathetic space to share, reflect, and connect with others who’re walking a similar path.
Whether you're seeking support after a clinical trial or treatment, these peer-led support circles are grounded in lived experience and focused on continued healing through community.
NOTE: Our peer support circles are non-clinical and do not replace medical, psychological, or emergency care.
Status: Open and running
MDMA-assisted therapy peer support circle (online & free)
We're currently running peer support group sessions for those who have legally undergone MDMA-assisted therapy for PTSD through clinical trials or global access programs, including Expanded Access (U.S.), Special Access Program (Canada), Compassionate Use (Switzerland), and the Authorized Prescriber Scheme (Australia).
Status: Coming soon
Psilocybin-assisted therapy peer support circle (online & free)
We'll be launching a peer support group for those who have legally undergone psilocybin-assisted therapy as a treatment for anxiety, depression, and existential distress through clinical trials or global access programs, including Special Access Program (Canada), Compassionate Use (Switzerland), and the Authorized Prescriber Scheme (Australia).
Status: Coming soon
Ketamine-assisted therapy peer support circle (online & free)
We'll be launching a peer support group for those who have legally undergone ketamine-assisted therapy as a treatment for depression, anxiety, PTSD, or chronic pain through medically supervised clinics.
November 20–22, 2026
Join a global, multi-stakeholder summit bringing patients, caregivers, clinicians, researchers, and organizations together to address safety, real-world outcomes, and support gaps after psychedelic treatment.
Want to contribute or collaborate? Have a resource to share? We’d love to hear from you! Contact us to submit a resource, recommend a topic, or get involved with our initiatives.
This page will continue to grow as we expand our offerings. Check back for new content and initiatives!
Get the latest expert insights and patient perspectives with the Psychedelic Lived Experiences Newsletter. Subscribe for events, news, resources, and more.